Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KKBordenave Consulting Group appears to be a small private healthcare and precision-medicine consulting business associated with physician executive Kristine Bordenave, MD. Public references link the firm to advisory work in precision medicine, population health, Medicare compliance, cost management, and healthcare delivery optimization rather than to proprietary drug development. The company has been mentioned in industry conference materials and speaker biographies focused on clinical laboratories, payer strategy, and personalized medicine. There is no evidence that it operates as a biotech, pharmaceutical, or therapeutic-product company with a clinical pipeline. Based on available public information, it is best characterized as a niche healthcare consulting practice serving stakeholders in diagnostics, payer, and healthcare operations contexts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KKBordenave Consulting Group.